By clicking “SEARCH” I agree to the current Intelius TERMS OF USE and PRIVACY POLICY, and agree not use the products or services of Intelius to determine one's eligibility for credit, housing, insurance, employment or any other reason subject to the Fair Credit Reporting Act (“FCRA”). I further understand that Intelius is not a “consumer reporting agency” and does not provide “consumer reports” under the FCRA.
One of the owners of (617) 231-6005 is between 60-70 years old. We have records for 7 possible previous addresses for the owner, 10 other possible phone numbers, and 2 possible related persons connected to this individual.
Executive Chair, Board of Directors at Rheostat Therapeutics (Since 2019)
Board of Directors at T1d Exchange (Since 2018)
Board of Directors, Chair Nominating and Governance Committee at Neuralstem, Inc. (Since 2017)
Chair of the Board of Directors at Exonics Therapeutics (Since 2017)
Executive Chair, Board of Directors, and Senior Advisor at Exonics Therapeutics (2016-2018)
External Oversight Committee-Blueprint Neurotherapeutics Network at National Institutes of Health (2015-2018)
Board of Directors, Advisor, Scientific Advisory Board Co-Chair at Vtesse, Inc. (2014-2017)
Board of Directors, Advisor, Scientific Advisory Board Chair at Vtesse, Inc. (Since 2014)
Business Advisory Board at Akashi Therapeutics, Inc. (2014-2017)
Board of Directors, Founder &Amp; Advisor at Cydan Development, Inc. (2014-2014)
Robertson Therapeutic Development Fund Review Committee at Rockefeller University (Since 2014)
Scientific Advisory Board at Cureduchenne (2013-2015)
Executive Oversight Board- Neuronext at National Institutes of Health (Since 2013)
President and Chief Executive Officer, Founder at Cydan Development, Inc. (2012-2014)
Venture Advisor at New Enterprise Associates (Nea) (2012-2014)
Board of Directors, Compensation Committee, Nominating and Governance Committee at Juniper Pharmaceuticals Inc. (Formerly Columbia Laboratories) (2010-2018)
Treat-Nmd Advisory Committee for Therapeutics at Treat-Nmd Neuromuscular Network (Since 2009)
Vice President, Drug Development at Virdante Pharmaceuticals (2009-2011)
Scientific Advisory Board-Mda Venture Philanthropy at Muscular Dystrophy Association (Since 2008)
Principal at Clarus Ventures (2006-2008)
Senior Director/Director, Translational Medicine/Clinical Development at Wyeth Research (1998-2006)
Director/Manager Clinical Development at Genetics Institute (1988-1998)
Clinical Pharmacist at Dana-Farber Cancer Institute (1983-1988)
Pharmacists (1984-2008)
Education
BS Pharmacy, Pharmd, Pharmacy from Massachusetts College of Pharmacy and Health Sciences (1980-1984)
Mhp, Research Methodology from Northeastern University
You can run a reverse phone lookup using the Intelius search engine to learn more about the owner of the number calling you. Intelius phone reports can include when available, name, age, address, possible associates, original line type, and phone carrier.
This site contains REAL public records data including criminal records, background reports, photos, court documents, address information, phone numbers, civil judgments, properties owned, social media profiles, and much more.
Intelius does not provide consumer reports and is not a consumer reporting agency. We provide sensitive information (criminal record, address, phone number, property, civil judgment, and more) that can be used to satisfy your curiosity, protect your family, and find the truth about people in your life. To use our site you must certify below by selecting "I Agree" that you agree to our PRIVACY POLICY and TERMS OF USE and will NOT use our site or the information we provide:
(1) to make decisions about or in connection with hiring, promoting, reassigning, or continuing to employ any person, including current or potential volunteers and household employees such as childcare workers, contractors, or home health aides;
(2) to make decisions about or in connection with renting or selling a house, apartment, or other residential property to any person;
(3) to make decisions about or in connection with lending money or extending credit to any person;
(4) in connection with the underwriting of insurance;
(5) for any purpose related to any eligibility determination about a person; or
(6) for any other purposes that would require FCRA compliance.
I AGREE
x
What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.